Johnson & Johnson Medical Devices Companies just launched the Biosense Webster, Inc.’s CARTONET to assist electrophysiologists, hospitals, health systems, and researchers with leveraging and sharing data to improve patient outcomes and operational efficiency in catheter ablation procedures.
The news was announced during Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Heart Rhythm Scientific Sessions. The company said in a statement that CARTONET is the world’s first cloud-based networking and data analytics software solution for the field of electrophysiology. CARTONET gives doctors and hospitals the ability to review, analyze and share case data, along with video and image files obtained during catheter ablation procedures with the CARTO 3 System, the company’s three-dimensional (3D) heart mapping system.
Catheter ablation is non-surgical treatment option for heart rhythm disorders including atrial fibrillation (AF) and works through neutralizing the abnormal electrical activity that causes an irregular heartbeat. Most patients who have the procedure, says the company, experience a long-term reduction in the number of episodes of arrhythmia and the severity of symptoms. A high percentage achieve a permanent return to normal heart rhythm.
With CARTONET, CARTO 3 Systems data will be stored on a secure cloud-based network where doctors can remotely access it via laptop, tablet or desktop. An interactive clinical dashboard provides statistics and analytics on case volume, lab utilization and procedural efficiency, among other data points. In addition, case data may be shared between institutions for clinical and research purposes.
CARTONET leverages the teamplay Cloud Platform of Siemens Healthineers, which meets industry best practices of security and privacy and supports compliance with HIPAA and GDPR.
“This is a very exciting development for the field of electrophysiology in that we will be able to more powerfully harness catheter ablation data to hone our own processes in the lab and to generate evidence and collaborate on research that could lead to new advances and improved patient outcomes,” said Jose Osorio, MD, Director, Cardiac Electrophysiology, Grandview Medical Center, Birmingham, AL, in the release.
